These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 12101079

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lack of association between the -260 C-->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels.
    Heesen M, Blömeke B, Schlüter B, Heussen N, Rossaint R, Kunz D.
    Intensive Care Med; 2001 Nov; 27(11):1770-5. PubMed ID: 11810121
    [Abstract] [Full Text] [Related]

  • 3. Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis.
    Shih HH, Lin TM, Chuang JH, Eng HL, Juo SH, Huang FC, Chen CL, Chen HL.
    Pediatrics; 2005 Aug; 116(2):437-41. PubMed ID: 16061600
    [Abstract] [Full Text] [Related]

  • 4. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
    Schippers EF, van 't Veer C, van Voorden S, Martina CA, Huizinga TW, le Cessie S, van Dissel JT.
    Cytokine; 2005 Mar 07; 29(5):215-28. PubMed ID: 15760678
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of CD14-c159T genotypes on the cytokine response to endotoxin by peripheral blood mononuclear cells from asthmatic children.
    Keskin O, Birben E, Saçkesen C, Soyer OU, Alyamaç E, Karaaslan C, Tokol N, Ercan H, Kalayci O.
    Ann Allergy Asthma Immunol; 2006 Sep 07; 97(3):321-8. PubMed ID: 17042137
    [Abstract] [Full Text] [Related]

  • 7. TNF-alpha promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin.
    Schippers EF, van 't Veer C, van Voorden S, Martina CA, le Cessie S, van Dissel JT.
    Cytokine; 2004 Apr 07; 26(1):16-24. PubMed ID: 15016407
    [Abstract] [Full Text] [Related]

  • 8. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
    El-Shabrawi Y, Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S, Ardjomand N, Hermann J.
    Ophthalmology; 2006 Apr 07; 113(4):695-700. PubMed ID: 16581430
    [Abstract] [Full Text] [Related]

  • 9. The tumor necrosis factor alpha -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia.
    Kovar FM, Marsik C, Cvitko T, Wagner OF, Jilma B, Endler G.
    Shock; 2007 Mar 07; 27(3):238-41. PubMed ID: 17304103
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection.
    Barrett S, Collins M, Kenny C, Ryan E, Keane CO, Crowe J.
    J Med Virol; 2003 Oct 07; 71(2):212-8. PubMed ID: 12938195
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
    Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiina S, Shiratori Y, Ito Y, Omata M.
    Hepatology; 2003 Jan 07; 37(1):65-71. PubMed ID: 12500190
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ, Nickerson P, Bernstein CN.
    Am J Gastroenterol; 2005 May 07; 100(5):1134-42. PubMed ID: 15842590
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma.
    Baştürk B, Yavaşçaoğlu I, Vuruşkan H, Göral G, Oktay B, Oral HB.
    Cytokine; 2005 Apr 07; 30(1):41-5. PubMed ID: 15784411
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients.
    Nakada TA, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, Watanabe E, Abe R, Hatano M, Tokuhisa T.
    J Surg Res; 2005 Dec 07; 129(2):322-8. PubMed ID: 16051275
    [Abstract] [Full Text] [Related]

  • 20. Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus.
    Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK.
    J Med Virol; 2004 Jan 07; 72(1):60-5. PubMed ID: 14635012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.